Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00587821 · ClinicalTrials.gov registry record
Peptide Profiles of Women Undergoing Breast Biopsy
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 571
- Enrollment target
NCT00587821: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00587821 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 571 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00587821 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 571 participants
- Enrollment target
Study Summary
This study is being done to learn about blood proteins. We want to see if the blood proteins in women whose biopsies show breast cancer are different from the blood proteins in women whose biopsies do not show breast cancer. The goal of this study is to develop a blood test than can help detect breast cancers when they are very small and easy to cure.
Interventions
- OTHER Blood draw
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 571 participants |
| Start Date | 2006-01 |
| Est. Completion | 2013-12 |
What the finished NCT00587821 record still lists
NCT00587821 is an observational study that tracks outcomes without assigning an intervention. The registered 571 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Blood draw is the first listed.
NCT00587821 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00587821 about?
NCT00587821 is a clinical study titled "Peptide Profiles of Women Undergoing Breast Biopsy". This study is being done to learn about blood proteins. We want to see if the blood proteins in women whose biopsies show breast cancer are different from the blood proteins in women whose biopsies do not show breast cancer. The goal of this study is to develop a blood test than can help detect brea...
What is the current status of trial NCT00587821?
This trial is currently completed. The enrollment target is 571 participants. The study started on 2006-01. Estimated completion is 2013-12.
What interventions are being tested in trial NCT00587821?
The interventions under investigation include: Blood draw (OTHER).
Who is sponsoring clinical trial NCT00587821?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04410796 · 571 participants · Phase 2
Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers
- NCT05131022 · 572 participants · Phase 1
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
- NCT06346392 · 572 participants · Phase 3
AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2
- NCT06615050 · 572 participants · Phase 3
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia